Former Neuralink President Launches Startup for Human Trials of Biohybrid Chip
Science Corporation, founded by the former President of Neuralink, is set to conduct human trials on a new biohybrid brain-computer interface (BCI). The company has recruited a leading neurobiologist to oversee the trials, which aim to explore the integration of biological tissue with electronic components. This innovative approach could open new avenues for neuroengineering and assistive technologies. The trials will assess the device's safety and effectiveness in a human setting, marking a significant advancement in the field. Experts are keenly observing these developments, as they could revolutionize how we interface with technology.
AlgoTrading